J & J is facing more than 2,000 lawsuits from plaintiffs who claim the company was slow in fully warning doctors about reports linking Levaquin to tendonitis and tendon ruptures. In a New Jersey state court in Atlantic City, lawyers for the drug maker told jurors that the Levaquin label had included information about tendon problems since the FDA approved the drug in 1996.
Read more here.
